A Randomized, Open-Label, Parallel Group Study to Evaluate the Efficacy and Safety of Proactive Management in Pediatric Subjects with Moderate to Severe Atopic Dermatitis

被引：0
|
作者：
Fukuie, Tatsuki [1 ,2 ]
Nomura, Ichiro [3 ]
Narita, Masami [2 ]
Suzuki, Tsukasa [1 ]
Tajima, Iwao [1 ]
Natsume, Osamu [1 ]
Taguchi, Tomohide [1 ]
Ogata, Tsutomu [1 ]
Tokura, Yoshiki [4 ]
Matsumoto, Kenji [3 ]
Ohya, Yukihiro [2 ]
机构：
[1] Hamamatsu Univ Sch Med, Dept Pediat, Shizuoka, Japan
[2] Natl Ctr Child Hlth & Dev, Dept Med Subspecialties, Div Allergy, Tokyo, Japan
[3] Natl Res Inst Child Hlth & Dev, Dept Allergy & Immunol, Tokyo, Japan
[4] Hamamatsu Univ Sch Med, Dept Dermatol, Shizuoka, Japan
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2013年 / 131卷 / 02期
关键词：
D O I：
10.1016/j.jaci.2012.12.1030
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：AB101 / AB101
页数：1
相关论文
共 50 条
  • [1] Safety and efficacy of lebrikizumab in adolescent patients with moderate-to-severe atopic dermatitis: an open-label study
    Paller, Amy
    Flohr, Carsten
    Eichenfield, Lawrence F.
    Irvine, Alan
    Pinto-Correia, Ana
    Natalie, Chitra R.
    Pierce, Evangeline
    Reifeis, Sarah
    Lima, Renata Gontijo
    Laquer, Vivian
    Weidinger, Stephan
    Isho, Nadine
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2023, 188
  • [2] Safety and efficacy of lebrikizumab in adolescent patients with moderate-to-severe atopic dermatitis: an open-label study
    Paller, Amy
    Flohr, Carsten
    Eichenfield, Lawrence F.
    Irvine, Alan D.
    Pinto-Correia, Ana
    Natalie, Chitra R.
    Pierce, Evangeline
    Reifeis, Sarah
    Lima, Renata Gontijo
    Laquer, Vivian
    Weidinger, Stephan
    [J]. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2023, 21 : 60 - 61
  • [3] Safety and efficacy of lebrikizumab in adolescent patients with moderate-to-severe atopic dermatitis: an open-label study
    Paller, Amy
    Flohr, Carsten
    Eichenfield, Lawrence F.
    Irvine, Alan
    Correia, Ana Pinto
    Natalie, Chitra R.
    Pierce, Evangeline
    Lima, Renata Gontijo
    Laquer, Vivian
    Weidinger, Stephan
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB84 - AB84
  • [4] A Randomized, Multicenter, Open-Label Phase 3 Study to Evaluate the Safety and Efficacy of Infliximab in Pediatric Patients With Moderate to Severe Ulcerative Colitis
    Hyarns, Jeffrey S.
    Damaraju, Lakshmi
    Blank, Marion
    Johanns, Jewel
    Guzzo, Cynthia
    Winter, Harland S.
    Kugathasan, Sabra
    Cohen, Stanley A.
    Markowitz, James
    Veereman, Gigi
    Crandall, Wallace
    Baldassano, Robert
    Griffiths, Anne M.
    [J]. GASTROENTEROLOGY, 2011, 140 (05) : S124 - S125
  • [5] A randomized, multicenter, open-label study to evaluate the safety and efficacy of infliximab in pediatric patients with moderate-to-severe Crohn's disease
    不详
    [J]. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2005, 41 (04): : 539 - 539
  • [6] Long-term safety and efficacy of open-label dupilumab in patients with moderate-to-severe atopic dermatitis
    Deleuran, M.
    Thaci, D.
    Beck, L.
    Forman, S.
    Soong, W.
    Hussain, I.
    Bissonnette, R.
    Bouaziz, J.
    Gelfand, J.
    Lawrence, S.
    Chen, Z.
    Akinlade, B.
    Gadkari, A.
    Eckert, L.
    Graham, N.
    Ardeleanu, M.
    [J]. AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2019, 60 : 34 - 34
  • [7] Long-Term Safety and Efficacy of Open-Label Dupilumab in Patients with Moderate-to-Severe Atopic Dermatitis
    Deleuran, Mette
    Thaci, Diamant
    Beck, Lisa A.
    Forman, Seth
    Soong, Weily
    Hussain, Iftikhar
    Bissonnette, Robert
    Bouaziz, Jean-David
    Gelfand, Joel
    Sher, Lawrence
    Chen, Zhen
    Akinlade, Bolanle
    Gadkari, Abhijit
    Eckert, Laurent
    Graham, Neil M. H.
    Pirozzi, Gianluca
    Ardeleanu, Marius
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2017, 139 (02) : AB381 - AB381
  • [8] INTERMITTENT PROACTIVE MAINTENANCE TREATMENT WITH 0.03% TACROLIMUS OINTMENT IN PEDIATRIC PATIENTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS: RESULTS FROM A MULTICENTER, OPEN-LABEL, RANDOMIZED, CONTROLLED STUDY
    Liu, Lingling
    Zhu, Xuejun
    Zhao, Zuotao
    Wang, Shan
    Ma, Lin
    Gu, Heng
    Wang, Hua
    Chen, Jinping
    Yao, Zhirong
    Chen, Ji
    [J]. JOURNAL OF DERMATOLOGY, 2014, 41 : 10 - 10
  • [9] A Phase 2, Open-label, Investigator-initiated Study to Evaluate the Safety and Efficacy of Apremilast in Subjects with Recalcitrant Contact or Atopic Dermatitis
    Volf, Eva
    Au, Shiu-Chung
    Dumont, Nicole
    Gottlieb, Alice
    [J]. CLINICAL IMMUNOLOGY, 2010, 135 : S107 - S107
  • [10] An Open-Label Prospective Study to Compare the Efficacy and Safety of Topical Fluticasone Versus Tacrolimus in the Proactive Treatment of Atopic Dermatitis
    Mudaliyar, Vinodhini R.
    Pathak, Asha
    Dixit, Alok
    Kumar, Sweta S.
    [J]. DERMATOLOGY PRACTICAL & CONCEPTUAL, 2020, 10 (04):
12345